Aniluxx Biotechnology, Inc. — Form D

Aniluxx Biotechnology, Inc. of CHAPEL HILL, NC, a company, filed a Form D exempt-offering notice with the SEC on 2019-12-20. The offering totals $750K, of which $200K was reported sold. Industry: Other Health Care.

Offering

• Filed: 2019-12-20
• Form: D
• Accession: 0001793334-19-000001
• Industry: Other Health Care
• Exemptions: 06b
• Total offering: $750K
• Amount sold: $200K
• Remaining: $550K
• Investors: 2
• Date of first sale: 2019-12-09
• Security types: debt
• Revenue range: Decline to Disclose
• SEC file number: 021-356161

Issuer

• Name: Aniluxx Biotechnology, Inc.
• CIK: 0001793334
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2019
• Address: 304 NOTTINGHAM DRIVE, CHAPEL HILL, NC, 27517
• Phone: 561-322-0170

Officers, directors & promoters (3)

More

• CIK 1793334 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search